Skip to main content

Research Repository

Advanced Search

All Outputs (157)

Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer: A Nationwide Registry-Based Study. (2021)
Journal Article
Mamas. (2021). Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer: A Nationwide Registry-Based Study. https://doi.org/10.1016/j.jaccao.2021.11.001

Background: Myocardial infarction is a cardiac adverse event associated with 5-fluorouracil (5-FU). There are limited data on the incidence, risk, and prognosis of 5-FU-associated myocardial infarction. Objectives: The aim of this study was to examin... Read More about Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer: A Nationwide Registry-Based Study..

In-Hospital Characteristics and 30-Day Readmissions for Acute Myocardial Infarction and Major Bleeding in Patients With Active Cancer. (2021)
Journal Article
Mamas. (2021). In-Hospital Characteristics and 30-Day Readmissions for Acute Myocardial Infarction and Major Bleeding in Patients With Active Cancer. The American Journal of Cardiology, 25 - 37. https://doi.org/10.1016/j.amjcard.2021.11.015

There are limited data on readmission with ischemic and major bleeding events in patients with acute myocardial infarction (AMI) with active cancer. The purpose of our study was to evaluate in-hospital characteristics and 30-day readmission rates for... Read More about In-Hospital Characteristics and 30-Day Readmissions for Acute Myocardial Infarction and Major Bleeding in Patients With Active Cancer..

Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation. (2021)
Journal Article
Mamas. (2021). Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation. The American Journal of Cardiology, 58 - 64. https://doi.org/10.1016/j.amjcard.2021.11.021

To compare the efficacy and safety of apixaban and rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation (NVAF) by way of a meta-analysis informed by real-world evidence. Systematic review and meta-analysis of obse... Read More about Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation..

Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review. (2021)
Journal Article
Mamas. (2021). Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review. Circulation: Heart Failure, e008685 - ?. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008685

BACKGROUND: Heart failure has a disproportionate burden on patients who are Black, Indigenous, and people of color (BIPOC), but not much is known about representation of these groups in randomized controlled trials (RCTs). We explored temporal trends... Read More about Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review..

Addressing disparities of care in non-ST-segment elevation myocardial infarction (NSTEMI) patients without standard modifiable risk factors: insights from a nationwide cohort study (2021)
Journal Article
Rashid, Mamas, & Nolan. (2021). Addressing disparities of care in non-ST-segment elevation myocardial infarction (NSTEMI) patients without standard modifiable risk factors: insights from a nationwide cohort study. European Journal of Preventive Cardiology, 1084-1092. https://doi.org/10.1093/eurjpc/zwab200

Background: The importance of standard modifiable cardiovascular risk factors (SMuRFs) in preventing non-ST segment myocardial infarction (NSTEMI) is established. However, NSTEMI may present in the absence of SMuRFs, and little is known about their o... Read More about Addressing disparities of care in non-ST-segment elevation myocardial infarction (NSTEMI) patients without standard modifiable risk factors: insights from a nationwide cohort study.

Corrigendum to: Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis. (2021)
Journal Article
Mamas. (2021). Corrigendum to: Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis. European Heart Journal: Acute Cardiovascular Care, 1101 - ?. https://doi.org/10.1093/ehjacc/zuab013

The Impact of Charlson Comorbidity Index on De Novo Cardiac Implantable Electronic Device Procedural Outcomes in the United States (2021)
Journal Article
Mohamed, M. O., Van Spall, H. G., Morillo, C., Wilton, S. B., Kontopantelis, E., Rashid, M., …Mamas, M. (2022). The Impact of Charlson Comorbidity Index on De Novo Cardiac Implantable Electronic Device Procedural Outcomes in the United States. Mayo Clinic Proceedings, 97(1), 88 - 100. https://doi.org/10.1016/j.mayocp.2021.06.029

OBJECTIVE: To investigate the utility of Charlson comorbidity index (CCI) as a measure of comorbidity burden to predict procedural outcomes after de novo cardiac implantable electronic device (CIED) implantation. METHODS: All de novo CIED implantatio... Read More about The Impact of Charlson Comorbidity Index on De Novo Cardiac Implantable Electronic Device Procedural Outcomes in the United States.

Trends of Sex Differences in Clinical Outcomes After Myocardial Infarction in the United States. (2021)
Journal Article
Rashid, & Mamas. (2021). Trends of Sex Differences in Clinical Outcomes After Myocardial Infarction in the United States. https://doi.org/10.1016/j.cjco.2021.06.012

Background: Female patients have been shown to experience worse clinical outcomes after acute myocardial infarction (AMI) compared with male patients. However, it is unclear what trend these differences followed over time. Methods: Data from patients... Read More about Trends of Sex Differences in Clinical Outcomes After Myocardial Infarction in the United States..

Analysis of a Web-Based Dashboard to Support the Use of National Audit Data in Quality Improvement: Realist Evaluation. (2021)
Journal Article
Mamas. (2021). Analysis of a Web-Based Dashboard to Support the Use of National Audit Data in Quality Improvement: Realist Evaluation. Journal of Medical Internet Research, e28854 - ?. https://doi.org/10.2196/28854

BACKGROUND: Dashboards can support data-driven quality improvements in health care. They visualize data in ways intended to ease cognitive load and support data comprehension, but how they are best integrated into working practices needs further inve... Read More about Analysis of a Web-Based Dashboard to Support the Use of National Audit Data in Quality Improvement: Realist Evaluation..

Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length (2021)
Journal Article
Shoaib, A., Mamas, M. A., Spratt, J. C., Curzen, N., Wilson, S., Rashid, M., …Kinnaird, T. (2021). Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length. Catheterization and Cardiovascular Interventions, 99(2), 234-244. https://doi.org/10.1002/ccd.30015

AbstractBackgroundLong lesions are known to have worse outcomes following percutaneous coronary intervention (PCI), but there are limited data assessing the association between lesion length and clinical outcomes in PCI procedures undertaken in chron... Read More about Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.

Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis. (2021)
Journal Article
Mamas, M., Latif, A., Ahsan, M. J., Lateef, N., Aurit, S., Mirza, M. M., …Velagapudi, P. (2022). Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis. Catheterization and Cardiovascular Interventions, 99(2), 254-262. https://doi.org/10.1002/ccd.30017

AbstractBackgroundWomen are underrepresented in chronic total occlusion (CTO) trials and little is known about sex differences in the outcomes of CTO percutaneous coronary intervention (PCI). This meta‐analysis aims to compare the outcomes of CTO PCI... Read More about Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis..

Dual pathway inhibition in atherothrombosis prevention: yes, now we can! (2021)
Journal Article
SUMMARIA, F., BIONDI-ZOCCAI, G., ROMAGNOLI, E., MAMAS, M. A., FRANCHI, F., SEVERINO, P., …BHATT, D. L. (2023). Dual pathway inhibition in atherothrombosis prevention: yes, now we can!. Minerva Cardiology and Angiology, 71(4), 363-373. https://doi.org/10.23736/S2724-5683.21.05867-1

Despite ongoing developments, prevention and treatment of atherothrombotic cardiovascular disease remains a common challenge. Antithrombotic options for cardiocerebrovascular disease prevention involves a choice between dual antiplatelet therapy (DAP... Read More about Dual pathway inhibition in atherothrombosis prevention: yes, now we can!.

Treatment Effect of Primary Percutaneous Coronary Intervention on In-Hospital Outcomes of Active Cancer Patients Presenting With ST-Elevation Myocardial Infarction (2021)
Journal Article
Mamas. (2021). Treatment Effect of Primary Percutaneous Coronary Intervention on In-Hospital Outcomes of Active Cancer Patients Presenting With ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology, B148 - B148

Background Primary percutaneous coronary intervention (pPCI) is the optimal strategy for coronary revascularization in patients presenting with ST-segment elevation myocardial infarction (STEMI). However, there are limited data on the utility of pPCI... Read More about Treatment Effect of Primary Percutaneous Coronary Intervention on In-Hospital Outcomes of Active Cancer Patients Presenting With ST-Elevation Myocardial Infarction.

Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a National Cohort (2021)
Journal Article
Rashid, & Mamas. (2021). Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a National Cohort. Journal of the American College of Cardiology, B131 - B132. https://doi.org/10.1016/j.jacc.2021.09.1176

'Meeting Abstract'

TCT-359 Treatment Effect of Primary Percutaneous Coronary Intervention on In-Hospital Outcomes of Active Cancer Patients Presenting With ST-Elevation Myocardial Infarction (2021)
Journal Article
Mohamed, M., Van Spall, H., Alkhouli, M., Khan, S., Barac, A., Shoaib, A., …Mamas, M. (2021). TCT-359 Treatment Effect of Primary Percutaneous Coronary Intervention on In-Hospital Outcomes of Active Cancer Patients Presenting With ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology, B148 - B148

Choice and Outcomes of Left Main Coronary Disease Revascularization Strategies in England Before and After the COVID-19 Era (2021)
Journal Article
Mamas, & Rashid. (2021). Choice and Outcomes of Left Main Coronary Disease Revascularization Strategies in England Before and After the COVID-19 Era. Journal of the American College of Cardiology, B27 - B27. https://doi.org/10.1016/j.jacc.2021.09.916

Methods All patients with LM disease (= 50% stenosis) undergoing coronary revascularization in England between January 1, 2017 and August 19, 2020 were included (n = 22,235), stratified by time period (pre-COVID: January 1, 2017 to February 29, 2020;... Read More about Choice and Outcomes of Left Main Coronary Disease Revascularization Strategies in England Before and After the COVID-19 Era.

TCT-66 Choice and Outcomes of Left Main Coronary Disease Revascularization Strategies in England Before and After the COVID-19 Era (2021)
Journal Article
Mohamed, M., Curzen, N., de Belder, M., Spratt, J., Rashid, M., Shoaib, A., …Mamas, M. (2021). TCT-66 Choice and Outcomes of Left Main Coronary Disease Revascularization Strategies in England Before and After the COVID-19 Era. Journal of the American College of Cardiology, B27 - B27. https://doi.org/10.1016/j.jacc.2021.09.916

Background There are limited data on the impact of the COVID-19 pandemic on left main (LM) coronary revascularization activity, choice of strategy, and post-procedural outcomes. Methods All patients with LM disease (= 50% stenosis) undergoing coronar... Read More about TCT-66 Choice and Outcomes of Left Main Coronary Disease Revascularization Strategies in England Before and After the COVID-19 Era.

TCT-323 Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a National Cohort (2021)
Journal Article
Shamkhani, W., Kinnaird, T., Wijeysundera, H., Ludman, P., Rashid, M., & Mamas, M. (2021). TCT-323 Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a National Cohort. Journal of the American College of Cardiology, B131 - B132. https://doi.org/10.1016/j.jacc.2021.09.1176

Background In contemporary practice, complex high-risk but indicated percutaneous coronary intervention (CHIP) is increasingly common. Data on race-based differences in the nature of CHIP and their clinical outcomes in patients with stable coronary a... Read More about TCT-323 Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a National Cohort.